Showing results (351-360 of 412) with videos related to
Sort By:
Pageof 42
Leukemia Research|May 4, 2004
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphomaFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.Cancer|August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodiesMaher Albitar, Kim-Anh Do, Marcella M Johnson, et al.British Journal of Haematology|November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.Innate Immunity|October 16, 2013
Complete Bordetella avium, Bordetella hinzii and Bordetella trematum lipid A structures and genomic sequence analyses of the loci involved in their modificationsAlexey Novikov, Nita R Shah, Sami AlBitar-Nehme, et al.BMC Medical Genetics|November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Ke Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemiaGary J Schiller, Susan M O'Brien, Arnaud Pigneux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic ModelInhye E Ahn, Xin Tian, David Ipe, et al.Blood|May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndromeHesham M Amin, Iman Jilani, Elihu H Estey, et al.Archives of Pathology & Laboratory Medicine|July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimensAziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.Pageof 42